A Phase II Trial of Weekly Intravenous Ranpirnase (Onconase®), a Novel Ribonuclease in Patients with Metastatic Kidney Cancer
- 1 August 2001
- journal article
- clinical trial
- Published by Springer Nature in Investigational New Drugs
- Vol. 19 (3) , 255-260
- https://doi.org/10.1023/a:1010633004157
Abstract
Ranpirnase (Onconase®) is the firstribonuclease to enter cancer clinicaltrials. In prior phase II trials,responses were seen in mesothelioma andother solid tumors. This phase II trialtested...Keywords
This publication has 30 references indexed in Scilit:
- DIAGNOSIS AND TREATMENT OF LEPTOMENINGEAL METASTASES IN A PATIENT WITH RENAL CARCINOMA RESPONDING TO 5-FLUOROURACIL AND GEMCITABINEJournal of Urology, 1999
- Kidney cancerThe Lancet, 1998
- Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell CarcinomaNew England Journal of Medicine, 1998
- Enhancement of Vincristine Cytotoxicity in Drug-Resistant Cells by Simultaneous Treatment With Onconase, an Antitumor RibonucleaseJNCI Journal of the National Cancer Institute, 1996
- RELATIONSHIP BETWEEN RESPONSE RATE AND MEDIAN SURVIVAL IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - COMPARISON OF ONCONASE(R) WITH OTHER ANTICANCER AGENTSInternational Journal of Oncology, 1995
- Refined 1·7 Å X-ray crystallographic structure of P-30 protein, an amphibian ribonuclease with anti-tumor activityJournal of Molecular Biology, 1994
- PHASE-I HUMAN CLINICAL-TRIAL OF ONCONASE(R) (P-30 PROTEIN) ADMINISTERED INTRAVENOUSLY ON A WEEKLY SCHEDULE IN CANCER-PATIENTS WITH SOLID TUMORSInternational Journal of Oncology, 1993
- Comparative molecular modeling and crystallization of P‐30 protein: A novel antitumor protein of Rana pipiens oocytes and early embryosProteins-Structure Function and Bioinformatics, 1992
- Tamoxifen and trifluoroperazine (Stelazine) potentiate cytostatic/cytotoxic effects of P‐30 protein, a novel protein possessing anti‐tumour activityCell Proliferation, 1990
- Cytostatic and Cytotoxic Effects of Pannon (P‐30 Protein), A Novel Anticancer AgentCell Proliferation, 1988